Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Authors:
- Philippe LabrunePLPhilippe Labrune
- Guillaume MorcretteGMGuillaume Morcrette
- Sandra RebouissouSRSandra Rebouissou
- Dominique FrancoDFDominique Franco
- Sophie PrévotSPSophie Prévot
- Alberto QuagliaAQAlberto Quaglia
- Pierre BedossaPBPierre Bedossa
- Louis LibbrechtLLLouis Libbrecht
- Luigi TerraccianoLTLuigi Terracciano
- G. Peter A. SmitGSG. Peter A. Smit
- Paulette Bioulac-SagePBPaulette Bioulac-Sage
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 58 (2) , 350-357
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Assistance Publique - Hôpitaux de Paris
- Association pour la Recherche sur le Cancer
- Australian Research Council
This publication has 36 references indexed in Scilit:
- Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular studyHistopathology, 2012
- Natural History of Hepatocellular Adenoma Formation in Glycogen Storage Disease Type IThe Journal of Pediatrics, 2011
- Role of Wnt/β-catenin signaling in liver metabolism and cancerThe International Journal of Biochemistry & Cell Biology, 2011
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasJournal of Experimental Medicine, 2011
- Glucose-6-phosphatase deficiencyOrphanet Journal of Rare Diseases, 2011
- Regulation of cancer cell metabolismNature Reviews Cancer, 2011
- The metabolic advantage of tumor cellsMolecular Cancer, 2011
- Metabolism and proliferation share common regulatory pathways in cancer cellsOncogene, 2010
- Hepatocellular adenoma management and phenotypic classificationHepatology, 2009
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursNature, 2008